BridgeMD
Understanding the Neurobiology of Pharmacologically-induced Acute Stress on Ethical Decisions
EU CTIS ID: 2023-508731-31-01
What this study is testing
The main objective of the trial is to observe the effects of yohimbine and/or hydrocortisone on moral judgement in military personnel.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age ≥ 18 years and < 60 years old.
- Active duty military member.
You likely can't join if
- Receiving current psychological treatment.
- Current or previous heart and/or vascular disease.
- Current or previous endocrine disease/endocrinal deficits.
- Use of recreational substances in the last four weeks.
- Medication use that interact with either yohimbine or hydrocortisone in the last week.
- Pregnancy, menstruation or contraceptives.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.